Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The setting of results obtained supports further pre-clinical research focused on refining dendrimer formulations, optimizing dosing regimens, and evaluating the therapeutic efficacy in vivo, within the complex brain microenvironment
Unit size: 5 mg per vial
Its multimodal mechanisms of action and excellent tolerability make it a promising candidate for adjunctive or standalone treatment in mood disorders
Interestingly, the glucagon-like peptide-1 receptor (GLP1R) agonist exenatide is another emerging nondopaminergic receptor-based treatment option and shows promising preclinical and clinical outcomes
US$ 28.18
US$ 20.23
US$ 24.31
US$ 20.85
US$ 20.83
